Flamel Technologies S.A. (ADR) (NASDAQ:FLML)
A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
portefeuille
(99.81)
Submitted: 12/15/2011 11:12:41 PM :
Start Price:
$5.61
FLML Score:
+16.45
There are currently 450 FLML shares in my "fund" with break-even of around 4.82 USD. http://caps.fool.com/Blogs/fund-trades/678775.
Recs
KimLanners
(< 20)
Submitted: 4/24/2011 2:15:52 AM :
Start Price:
$6.20
FLML Score:
+6.43
nanobiotech good technicals
Recs
jahjimhall
(< 20)
Submitted: 12/30/2010 6:38:05 PM :
Start Price:
$6.83
FLML Score:
+9.96
No new drugs for a long time....
Recs
face2thehighfog
(80.34)
Submitted: 9/18/2009 10:38:47 AM :
Start Price:
$9.55
FLML Score:
-56.45
nano!
Recs
AAAAmanda
(38.88)
Submitted: 2/2/2009 2:37:12 PM :
Start Price:
$4.19
FLML Score:
-8.53
5.1172 at $111.00 or 21.69 per share. Can't do much worse.
Recs
stallis
(95.63)
Submitted: 1/16/2009 12:46:53 PM :
Start Price:
$33.40
FLML Score:
-81.07
It would be difficult for me to be more wrong about a stock than I was with this one. I got caught up in the "potential" of their technology and ignored their poor execution.
Recs
zoiebelle
(36.98)
Submitted: 6/4/2008 10:10:50 PM :
Start Price:
$10.45
FLML Score:
-36.97
Niche in medical technology will pay off.
Recs
WERDOSD44
(61.27)
Submitted: 3/24/2008 4:17:03 PM :
Start Price:
$8.96
FLML Score:
-29.33
THIS STOCK HAS BEEN AT $31.96, BELIEVE ITS ON ITS WAY TO THAT AREA AGAIN
Recs
gdufour
(52.16)
Submitted: 1/16/2008 5:50:39 AM :
Start Price:
$9.40
FLML Score:
-31.41
Never stays above 30, but surely gets there every now and then, so at a price below 10, this is a good bargain.
Recs
nmhiplains
(80.67)
Submitted: 1/14/2008 10:07:03 PM :
Start Price:
$9.54
FLML Score:
-30.67
Drug release procall for insulin
Recs
taryntoo
(< 20)
Submitted: 12/26/2007 12:14:19 AM :
Start Price:
$10.70
FLML Score:
-32.24
Bought at the bottom of their 52 week range. Not sure even that price is justified, but hoping their delivery technology will find new markets.
Recs
PicoTrader
(< 20)
Submitted: 10/19/2007 1:14:42 PM :
Start Price:
$8.15
FLML Score:
-11.56
purely a play on the fallen who should get up, even if its to a crawling position....
Recs
Recs
scrubs620
(38.66)
Submitted: 9/12/2007 8:01:25 PM :
Start Price:
$9.95
FLML Score:
-28.58
New license with Wyeth for the use of its protein delivery system.
Recs
miralooku
(65.51)
Submitted: 9/8/2007 5:55:35 AM :
Start Price:
$9.14
FLML Score:
-23.99
Powerful technology, activist investors, and 52-low price adds up to a market over-reaction. Buy now sit back, and enjoy the ride. This will return at least 50% in the next year or so.
Recs
tharlow
(< 20)
Submitted: 8/30/2007 8:10:48 AM :
Start Price:
$9.52
FLML Score:
-27.60
The French are now our friends.
Recs
paranakyry
(< 20)
Submitted: 8/23/2007 2:24:01 PM :
Start Price:
$10.17
FLML Score:
-31.43
Negative news at Glaxo has this name oversold. At today's price, I think this will outperform.
Recs
javnnf
(< 20)
Submitted: 8/17/2007 6:57:03 PM :
Start Price:
$12.42
FLML Score:
-44.05
badly beaten up!
Recs
romad829
(30.43)
Submitted: 8/9/2007 8:25:04 PM :
Start Price:
$15.81
FLML Score:
-56.02
I think this is about as low as it will get.
Recs
fredericch
(99.42)
Submitted: 7/31/2007 8:41:19 PM :
Start Price:
$16.86
FLML Score:
-58.10
Coreg CR is slow on the pick up, but it will eventually be the primary version of Coreg prescribed. The first quarter numbers of sales were slow, so the stock has pulled back, ready to spring even further!
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 51 : 1 2 3 Next »